Tranexamic Acid Dosing Guidelines

Standard Adult Dosing Protocol

• The standard dose of tranexamic acid is 1g IV over 10 minutes, followed by 1g infusion over 8 hours, which must be administered within 3 hours of bleeding onset for maximum efficacy 1, 2
• Loading dose: 1g (1000 mg) IV administered over 10 minutes 1, 2
• Maintenance infusion: 1g IV over 8 hours for procedures expected to exceed 2-3 hours 1

Critical Timing Considerations

• Administer within 3 hours of bleeding onset - this is the evidence-based window for maximum efficacy 1, 2
• Effectiveness decreases by 10% for every 15-minute delay in administration 1, 3
• Administration within 1 hour of injury reduces bleeding death by 32% 1
• Administration after 3 hours may paradoxically increase bleeding death risk and should be avoided 1, 2

Context-Specific Dosing Variations

Oral Administration

• For epistaxis/GI bleeding in HHT, start at 500 mg twice daily, gradually increasing up to 1000 mg four times daily or 1500 mg three times daily 4
• Contraindications include recent thrombosis; relative contraindications include atrial fibrillation or known thrombophilia 4

Pediatric Dosing

• Loading dose: 15 mg/kg IV over 10 minutes 3
• Maintenance infusion: 2 mg/kg/hour for 8 hours 3
• Maximum total dose: Do not exceed 100 mg/kg to reduce seizure risk 3

Key Clinical Pitfalls to Avoid

• Do not delay administration waiting for diagnostic workup or viscoelastic testing - early administration is critical 1, 3
• Do not use topical TXA as a substitute for IV TXA when systemic hemostatic support is needed 1
• Do not administer after 3 hours from bleeding onset, as this may increase mortality 1, 2
• Monitor for seizures with higher doses, particularly in cardiac surgery or when exceeding 100 mg/kg in pediatrics 1, 3

Safety Profile

• No increased risk of arterial or venous thrombotic events demonstrated in over 8,000 patients receiving TXA 1
• Meta-analysis of 125,550 participants confirms safety with no increased thromboembolic risk 1

Systemic Intravenous Administration is Superior to Nebulized Tranexamic Acid

Guideline-Based Route of Administration

• The American College of Critical Care recommends intravenous administration for all major bleeding indications, while nebulized TXA lacks guideline support and carries significant neurotoxicity risk 5, 6
• All major international guidelines exclusively recommend intravenous administration for trauma, major surgery, postpartum hemorrhage, and other bleeding emergencies 5, 6

Critical Safety Concerns with Nebulized TXA

• The Association of Anaesthetists 2025 guidelines do not include nebulization as an acceptable route for any clinical setting, due to documented neurotoxicity risk 6

Evidence Base Comparison

• The CRASH-2 trial demonstrated that IV TXA significantly reduced all-cause mortality and death due to bleeding in trauma patients, with a relative risk of 0.91 and 0.85 respectively 5
• Multiple randomized controlled trials across trauma, surgery, and obstetrics support IV administration, with high strength of evidence 5, 6

Clinical Algorithm for Route Selection

• The American Heart Association recommends using IV TXA for all trauma patients with bleeding or at risk of significant hemorrhage, within 3 hours of injury 5
• The American College of Obstetricians and Gynecologists recommends using IV TXA for postpartum hemorrhage, within 3 hours of bleeding onset 6
• The European Society of Anaesthesiology recommends using IV TXA for major surgery, including cardiac, orthopedic, and non-cardiac procedures 6